| Disease Name |
Medulloblastoma |
| Nocoding RNA Name |
hsa-miR-9 |
| Expression Pattern |
down-regulated |
| Species |
Homo sapiens |
| Detection Methods |
qRT-PCR,methylation-specific PCR,Western Blot,immunofluorescence analysis etc. |
| Target |
N/A |
| Tissue |
medulloblastoma cell lines |
| Treatment |
N/A
|
| PubMed ID |
24346283 |
| Year |
2014 |
| Detail Description |
Compared with normal human fetal cerebellum, a decreased expression level of miR-9 was observed in the majority of MB tumour tissues and in all the six MB cell lines tested. Low microRNA-9 expression correlates significantly with the diagnosis of unfavourable histopathological variants and with poor clinical outcome. microRNA-9 silencing occurs via cancer-specific CpG island hypermethylation. HES1 was identified as a direct target of microRNA-9 in medulloblastoma, and restoration of microRNA-9 was shown to trigger cell cycle arrest, to inhibit clonal growth and to promote medulloblastoma cell differentiation. |
|